4 free views remaining today

retinitis pigmentosa 7

ICD-10 Codes

Related ICD-10:

Description

Retinitis Pigmentosa (RP): A Progressive Vision Disorder

Retinitis pigmentosa, as described in search result #7, is a serious inherited eye disease that causes progressive loss of night and peripheral vision. This condition often leads to legal blindness, which can significantly impact an individual's quality of life.

  • Progressive Vision Loss: RP is characterized by the gradual deterioration of the retina, leading to impaired vision.
  • Night Blindness: One of the early symptoms of RP is difficulty seeing in low light conditions.
  • Peripheral Vision Loss: As the disease progresses, individuals may experience a decline in their ability to see objects or movement outside of their central visual field.

It's essential for individuals with RP to seek medical attention from an eye care professional for proper diagnosis and management. Early detection can help slow down the progression of the disease and improve overall vision outcomes.

Additional Characteristics

  • Night Blindness
  • Progressive Vision Loss
  • Peripheral Vision Loss

Signs and Symptoms

Early symptoms of retinitis pigmentosa include defective night vision and peripheral vision.

Diagnose by hyperpigmentation in a bone-spicule configuration on the retina, which is a characteristic feature of this condition [7].

  • Defective night vision: This is often one of the first signs of retinitis pigmentosa, where individuals have difficulty seeing in low light conditions.
  • Peripheral vision loss: As the disease progresses, people with retinitis pigmentosa may experience a gradual loss of peripheral (side) vision.

These symptoms can be subtle at first and may not be immediately noticeable. However, as the condition advances, they can become more pronounced and affect daily life [7].

Additional Symptoms

Diagnostic Tests

Retinitis pigmentosa (RP) is a group of inherited eye diseases that affect the retina, and diagnostic tests play a crucial role in confirming the diagnosis. Here are some diagnostic tests associated with RP:

  • Electroretinogram (ERG): This is considered the most critical diagnostic test for RP because it provides an objective measure of rod and cone function across the retina [5]. ERG measures the electrical activity of the retina in response to light stimuli.
  • Fundus examination: A comprehensive eye examination that includes dilating your eyes and using an ophthalmoscope to look at the back of the eye can reveal pigment clumps or deposits in the retina, a common feature of RP [8].
  • Retinal exam: A retinal exam is essential for diagnosing RP. An ophthalmologist will use an ophthalmoscope to examine the retina for signs of degeneration and loss of rod photoreceptor cells [9].
  • Eye chart test: This test assesses visual acuity, which can be affected in individuals with RP [7].
  • Color vision test: Individuals with RP may experience color blindness or difficulty perceiving colors, making this test relevant to the diagnosis [7].
  • Retinal ultrasound: This imaging technique can help identify retinal degeneration and loss of rod photoreceptor cells associated with RP [6].

It's essential to note that a comprehensive eye examination by an ophthalmologist is necessary for diagnosing RP. These tests may be ordered in conjunction with each other to confirm the diagnosis.

References: [5] - May 16, 2024 — Electroretinogram. [7] - How is retinitis pigmentosa diagnosed? · Eye chart test · Refraction test, to see if you need glasses · Color vision test · Retinal exam · Eye ultrasound ... [8] - Nov 6, 2024 — The presence of pigment clumps or deposits in the retina, commonly observed during histopathological examination (microscopic analysis of the ... [9] - Retinitis pigmentosa is characterized by retinal pigment deposits visible on fundus examination and primary loss of rod photoreceptor cells followed by ...

Additional Diagnostic Tests

  • Electroretinogram (ERG)
  • Fundus examination
  • Color vision test
  • Retinal exam
  • Eye chart test
  • Retinal ultrasound

Treatment

Current Drug Treatments for Retinitis Pigmentosa

According to search result [7], the FDA has approved voretigene neparvovec-rzyl (Luxturna), a gene therapy product, to treat a specific type of retinitis pigmentosa. This treatment targets people with mutations in the RPE65 gene.

Other Emerging Treatments

While Luxturna is a significant breakthrough, it's essential to note that there are other emerging treatments being developed for retinitis pigmentosa. For instance, researchers are exploring the potential of N-acetylcysteine-amide (NACA) as a treatment for this condition [3]. Additionally, gene therapies like AGN-151597, GS-030, and VMCO-1 are also in late-stage development [1].

Neuroprotective Agent Therapy

Research suggests that neuroprotective agent therapy may have the potential to slow the progression of RP in early stages of the disease [6]. This approach aims to protect the retina from further damage.

Other Conventional Therapies

While not specifically targeting retinitis pigmentosa, conventional therapies like retinoids and vitamin A supplements can help slow down the progression of the disease [9]. However, these treatments are not a cure for RP.

It's worth noting that there is currently no cure for retinitis pigmentosa, but researchers are working hard to find new treatments.

Recommended Medications

  • N-acetylcysteine-amide (NACA)
  • AGN-151597
  • GS-030
  • VMCO-1
  • voretigene neparvovec-rzyl (Luxturna)
  • Neuroprotective agent therapy
  • vitamin A
  • Vitamin A

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

Differential Diagnosis of Retinitis Pigmentosa

Retinitis pigmentosa (RP) is a group of inherited eye diseases that can be challenging to diagnose due to its similarity with other conditions. The differential diagnosis of RP involves identifying and ruling out other disorders that may present with similar symptoms.

Common Differential Diagnoses:

  • Usher syndrome: A genetic disorder characterized by progressive hearing loss and vision impairment.
  • Choroideremia: A rare inherited eye disease that affects the choroid layer of the retina, leading to progressive vision loss.
  • Leber congenital amaurosis (LCA): A rare inherited eye disease that causes severe visual impairment from birth.
  • Cone dystrophy: A group of inherited eye diseases that affect the cone cells in the retina, leading to progressive vision loss.
  • Cone-rod dystrophy: A rare inherited eye disease that affects both cone and rod cells in the retina, leading to progressive vision loss.

Other Conditions to Consider:

  • Night blindness due to other causes such as vitamin A deficiency or cataracts
  • Retinal degeneration due to age-related macular degeneration (AMD)
  • Other retinal dystrophies such as Stargardt disease or Best vitelliform macular dystrophy

Key Points to Remember:

  • RP is a group of inherited eye diseases that can be challenging to diagnose.
  • The differential diagnosis of RP involves identifying and ruling out other disorders that may present with similar symptoms.
  • Common differential diagnoses include Usher syndrome, choroideremia, LCA, cone dystrophy, and cone-rod dystrophy.
  • Other conditions such as night blindness due to other causes or retinal degeneration due to AMD should also be considered.

References:

[6] Usher syndrome, choroideremia, Leber congenital amaurosis (LCA), cone dystrophy and cone-rod dystrophy are the most important differential diagnoses of RP. [5] The differential diagnosis of retinitis pigmentosa is vast, and the combination of multiple causative genes and broad range of clinical severity has made both ... [8] Differential diagnosis of retinitis pigmentosa. Other disorders may be confused with RP either because there is symptomatic night blindness or because of a ...

Additional Differential Diagnoses

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_4737
owl#annotatedSource
t366440
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#hasDbXref
MIM:608133
oboInOwl#id
DOID:0110383
core#notation
DOID:0110383
IAO_0000115
A retinitis pigmentosa that has_material_basis_in mutation in the PRPH2 gene on chromosome 6p21.
rdf-schema#label
retinitis pigmentosa 7
oboInOwl#hasExactSynonym
RP7
rdf-schema#subClassOf
t366064
IDO_0000664
http://purl.obolibrary.org/obo/GENO_0000930
relatedICD
http://example.org/icd10/H35.5
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.